Skip to main content

Table 2 Characteristics among patients with Antiphospholipid Syndrome

From: The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study

  Antiphospholipid Syndrome (n = 19,163)
Characteristics n %
Age, years
 0–10 3242 16.92
 11–20 1112 5.80
 21–30 1964 10.25
 31–40 2709 14.14
 41–50 2021 10.55
 51–60 2150 11.22
 61–70 2031 10.60
 71–80 2368 12.36
  > 80 1566 8.16
mean ± SD 43.02 ± 26.45  
Gender
 Female 11,237 58.64
 Male 7926 41.36
Comorbidity
 Diabetes mellitus 3548 18.51
 Hypertension 3632 18.95
 Hyperlipidemia 2729 14.24
 Stroke 4006 20.90
 Heart failure 2646 13.81
 Atrial fibrillation 411 2.15
 Myocardial infarction 2197 11.46
 PAOD 1879 9.81
 Chronic kidney disease 3072 16.03
 COPD 3672 19.16
 Deep vein thrombosis 1167 6.09
 Pulmonary embolism 410 2.14
 Systemic lupus erythematosus 419 2.19
 Rheumatoid arthritis 816 4.26
 Systemic sclerosis 53 0.28
 Sjogren’s syndrome 498 2.6
 Polymyositis & dermatomyositis 34 0.18
  1. Data shown as n(%) or mean ± SD